SusanneBaumeisterMD
Pediatric Hematology & Oncology • Boston, MAClinical Fellow in Pediatrics, Boston Children's Hospital
Dr. Baumeister is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
300 Longwood Ave
Boston, MA 02115Phone+1 617-632-4687Fax+1 617-632-5710
Education & Training
Boston Children’s Hospital/Boston Medical CenterFellowship, Pediatric Hematology/Oncology, 2009 - 2012
University of WashingtonResidency, Pediatrics, 2006 - 2009
Brown UniversityInternship, Transitional Year, 2005 - 2006
Ludwig Maximilian University of Munich Faculty of MedicineClass of 2004
Certifications & Licensure
MA State Medical License 2009 - 2026
WA State Medical License 2006 - 2009
RI State Medical License 2005 - 2006- American Board of Pediatrics Pediatrics
- American Board of Pediatrics Pediatric Hematology-Oncology
Clinical Trials
- Safety Study of Chimeric Antigen Receptor Modified T-cells Targeting NKG2D-Ligands Start of enrollment: 2015 Mar 01
- A Phase 1 Trial of CIML NK Cell Infusion for Myeloid Disease Relapse After Hematopoietic Cell Transplantation Start of enrollment: 2019 Aug 31
Roles: Contact, Principal Investigator
- Naive T Cell Depletion for Preventing Chronic Graft-versus-Host Disease in Children and Young Adults With Blood Cancers Undergoing Donor Stem Cell Transplant Start of enrollment: 2019 Aug 29
Roles: Principal Investigator, Contact
Publications & Presentations
PubMed
- 642 citationsCoinhibitory Pathways in Immunotherapy for Cancer.Susanne H.C. Baumeister, Gordon J. Freeman, Glenn Dranoff, Arlene H. Sharpe
Annual Review of Immunology. 2016-05-11 - 208 citationsPhase I Trial of Autologous CAR T Cells Targeting NKG2D Ligands in Patients with AML/MDS and Multiple MyelomaSusanne H.C. Baumeister, Joana M. Murad, Lillian Werner, Heather Daley, Helene Trebeden-Negre
Cancer Immunology Research. 2019-01-01 - 40 citationsChimeric Antigen Receptor T Cells Targeting NKG2D-Ligands Show Robust Efficacy Against Acute Myeloid Leukemia and T-Cell Acute Lymphoblastic Leukemia.Lina Driouk, Joanina K. Gicobi, Yusuke Kamihara, Kayleigh Rutherford, Glenn Dranoff
Frontiers in Immunology. 2020-12-15
Press Mentions
Childhood Cancer Awareness Month: 2020 Immunotherapy Research UpdatesSeptember 24th, 2020- Combining CAR-T Cells and Inhibitor Drugs for High-Risk NeuroblastomaFebruary 17th, 2024
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
